Blauvelt, Andrew, Lawrence Eichenfeld, Michael Kuligowski, May Venturanza, Kang Sun, and Jonathan Silverberg. “Long-Term Safety and Disease Control With Ruxolitinib Cream Among Patients With Atopic Dermatitis Based on Previous Medication History: Pooled Results from Two Phase 3 Studies”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s65. Accessed July 7, 2022. https://www.jofskin.org/index.php/skin/article/view/1416.